P-glycoprotein (Pgp), the major mediator of multidrug resistbeen implicated as a major cause of the multidrug resistance ance (MDR) has often been implicated as a poor prognostic (MDR) phenotype. 14 A more recent study of adult AML failed to con- series. This suggests that the initial study may have selected a
group of very high c-Kit expressing AMLs which showed poor remission, either due to high c-Kit expression itself or other unidentified factors. Thus, whether c-Kit expression is a Introduction reliable and valid prognostic marker in adult AML remains to be determined. The potential of transformed cells to resist the action of cytoBoth c-Kit and Pgp are expressed by the CD34 + progenitor toxic agents has severely reduced both the immediate and cell population in normal bone marrow and both have been long-term efficacy of chemotherapy. Treatment of acute associated with poor prognosis in AML. The aim of this invesmyeloid leukaemia (AML) with daunorubicin/cytosine arabitigation was to determine whether the prognostic significance noside combination chemotherapy has proved effective in of high c-Kit expression in AML could be attributed to coinducing high rates of complete remission. However, early expression of Pgp and/or the MDR phenotype. relapse and subsequent unresponsiveness to further therapy demonstrate the ineffectiveness of current regimens to completely destroy the leukaemic population, most importantly Materials and methods leukaemic 'stem' cells. These cells provide a major impediment due to their innate chemoresistance and ability to reconLeukaemic specimens and normal bone marrow stitute the post-therapy leukaemic population. An important factor contributing to the chemoresistance of immature cells Leukaemic samples consisted of peripheral blood or bone is the expression of P-glycoprotein (Pgp), 1 a 170 kDa transmarrow specimens from 50 de novo AML patients diagnosed membrane glycoprotein which acts as an ATP-dependent drug at the Royal Adelaide Hospital. Samples containing Ͼ30% efflux pump. Pgp has been demonstrated to export a broad blasts were obtained at disease presentation and the monospectrum of structurally dissimilar drugs/compounds and has nuclear fraction isolated and cryopreserved as described previously. 16 FAB classifications were available for 37 patients, as follows: M1, 12; M2, eight: M3, two; M4, eight; M5, three; marrow mononuclear cells (BMMNC), from normal volun-10, 20 and 40 min data points ( Figure 1 ). treated as for the Rh123 efflux assay with the addition of UIC-2 (20 g/ml) before the loading period and after washing. BMMNC were then enriched for immature haemopoietic progenitors by differential agglutination using the soybean agglutRh123 efflux was then calculated as before. Daunorubicin uptake studies on cell lines were carried out as previously inin (SBA) (Vector Laboratories, Burlingame, CA, USA). 17 SBA − cells were separated by unit gravity sedimentation over 5% described. 19 Briefly, cells at 1 × 10 6 /ml were incubated in the presence of 3 g/ml daunorubicin with or without CsA bovine serum albumin (BSA) (Sigma, St Louis, MO, USA), washed once in phosphate-buffered saline (PBS), sup-(3 g/ml) for 30 min at 37°C. Cells were then washed and resuspended in PBS before flow cytometric analysis. Percentplemented with 200 mM D-galactose, then resuspended in RPMI 1640 (Gibco) supplemented with 10% FCS. SBA enrichage daunorubicin effluxed was calculated as: 100 − (mean fluorescence without CsA/mean fluorescence with CsA) × 100, ment routinely results in three-to four-fold increase in the proportion of CD34 + progenitor cells with Ͼ80% recovery. after correction for autofluorescence.
Indirect immunofluorescence labelling Cell Lines
The CCRF-CEM and CEM/VLB 100 cell lines 18 were obtained, Cells were washed three times in PBS containing 0.1% BSA and 0.1% sodium azide (PBA). After resuspension in PBA conrespectively, from the American Type Culture Collection (ATCC) and Dr David Ma, Royal North Shore Hospital, Sydtaining 10% heat inactivated normal rabbit serum (NRS), aliquots of 5 × 10 5 cells were incubated in the presence of ney, Australia. All other cell lines were as previously described.
14 All lines were screened for the presence of mycoappropriate Mab (10 g/ml) or isotype-matched negative control Mab (10 g/ml) at 4°C for 45 min. After washing three plasma. Only the CEM/VLB 100 line showed evidence of mycoplasma contamination.
times in PBA, cells were incubated for 45 min at 4°C in the appropriate secondary antibody coupled to fluorochrome,
Monoclonal antibodies
The anti-Pgp Mab UIC-2 (IgG2a) and MRK-16 (IgG2a) were purchased from Coulter (Hialeah, FL, USA) and Kamiya Biomedical Company (Thousand Oaks, CA, USA) respectively, and were used at 10 g/ml unless otherwise specified. The Mab YB5.B8 (IgG1), directed against c-Kit, 6, 12 was protein A purified and used at 10 g/ml. Anti-CD34 Mab 12.8 (IgM), supplied courtesy of Dr R Berenson (CellPro, Seattle, WA, USA), was used at a final concentration of 40 g/ml. Nonbinding isotype-matched control antibodies were purified and used at 10 or 40 g/ml as specificity controls.
Rhodamine 123 (Rh123) efflux and daunorubicin uptake studies
The MDR phenotype was assessed by Rh123 efflux in the presence and absence of the Pgp inhibitor cyclosporin A (CsA) (Sandoz, Basle, Switzerland). Briefly, cells at 1 × 10 6 /ml in RPMI 1640, supplemented with 10% FCS, were stained with 150 ng/ml Rh123 (Molecular Probes, Eugene, OR, USA) at 37°C for 10 min in either the presence or absence of 3 g/ml CsA. Cells were then centrifuged and resuspended back to 1 × 10 6 /ml in Rh123 free media. CsA was again added to those were then allowed to efflux dye at 37°C and 5 and c-Kit was carried out using UIC-2 and YB5.B8 followed meter in the appropriate fluorescence channels, FL-2 for PE by goat anti-mouse IgG2a R-phycoerythrin and goat antiand FL-3 for Tricolor. All assays were standardized in FL-2 mouse IgG1 Tricolor. Binding of the anti-Pgp MAb, MRK-16, and FL-3 with ST Brite beads and all positive-negative cutoff was also assessed. Figure 2 shows Pgp expression, measured values set at the 99th percentile of isotype-matched negative by UIC-2 binding, Rh123 efflux capacity and YB5.B8 binding control Mab.
for the range of cell lines examined. Spearman rank correlation of Pgp expression with dye efflux showed that there was a statistically significant relationship between expression of
Three-colour analysis of normal bone marrow
Pgp and dye efflux (r s = 0.85, P = 0.0007) for the cell lines examined. The low Pgp expression yet high efflux capacity of Normal BMMNC were obtained as described, placed in RPMI KG1 may indicate that very little Pgp is required to confer 1640 supplemented with 10% FCS and allowed to equilibrate functional efflux or that there is an alternative efflux mechfor 3 h at 37°C in 5% CO 2 in air. Cells were then labelled anism present in these cells as discussed further below. Funcwith Rh123 as for the efflux assay, washed and allowed to tional dye efflux did not correlate with c-Kit expression efflux dye over a 3 h period at 37°C/5% CO 2 . The efflux reac-(r s = −0.29, P = 0.39), nor did c-Kit and Pgp expression tion was terminated by the addition of CsA and placing the (r = −0.002, P = 0.99) for the panel of cell lines examined. cells on ice. Cells were than labelled by indirect immunofluorescence with UIC-2 or MRK-16 and 12.8, with appropriate isotype-matched negative controls, as described.
Results

Assay of functional drug efflux
Preliminary studies on the various cell lines provided the basis for the establishment of a quantitative drug efflux assay using the fluorescent dye Rh123. The dye efflux protocol used in this study was essentially the same as has been used previously, 1, 20 with the exception that control cells were incubated in the presence of CsA during the Rh123 loading period as well as during the efflux incubation. Since Pgp acts to promote the efflux of dye from the cytosol, thus preventing equilibration of dye, the addition of CsA to inhibit Pgp activity allowed the cells to be maximally loaded. The relevance of this can be seen in Figure 1b where immediately after the Rh123 loading period test HEL-DR cells (loaded without CsA) contained only 55% of the dye seen in the CsA+ control cells. Thus the addition of CsA to the control cells throughout the efflux protocol provides two measurements: (1) a decrease in dye content immediately after Rh123 loading and (2) a quantitative rate of dye efflux over the 40 min incubation. Although either measurement could be used to assess dye efflux activity, the latter was chosen since several data points contributed to the final result. The use of several time points during the efflux period (in contrast to many other studies) enabled a true rate of efflux to be determined. Data obtained by this method were both quantitative and highly reproducible. No efflux was observed in the presence of CsA in any cell line or AML specimen. Comparison with the daunorubicin accumulation method on a panel of 11 cell lines showed the two to be well In order to compare the levels of Pgp in the leukaemic specimens to the normal physiological level, Pgp expression in normal BMMNC was determined by three-colour flow cytometric analysis. Pgp expression was detected by both UIC-2 and MRK-16 and analysis by backgating revealed that the positive cells were in the lymphoid/blast region based on two-dimensional light scatter characteristics, as has been previously described. 1 To quantitate the level of Pgp expression within the various compartments of the lymphoid/blast population, these populations were gated based on their expression of the haemopoietic progenitor cell marker, CD34, and UIC-2 and MRK-16 binding were assessed (Figure 3 ) in two separate 
Functional and phenotypic analysis of AML samples
With the level of Pgp expression in normal bone marrow established, leukaemic samples were screened for Pgp, c-Kit expression and Rh123 efflux capacity. Pgp and c-Kit expression were measured by indirect immunofluorescence using Mabs UIC-2 and YB5.B8, respectively. Pgp expression was also assessed by binding of MRK-16, which detects a dif- trating the homogeneous blast population. Note that the use of cryopreserved material results in enrichment of the blast cell population as a result of selective loss of maturing min or 3 h did not significantly modulate the rate of Rh123 efflux in nine leukaemic specimens examined or the HEL-DR myeloid cells. 23 With gates set on the 99th percentile of isotype-matched negative control antibodies, Figure 4b illustrates line (data not shown). The leukaemic specimens tested were selected based on their moderate to high expression of c-Kit the homogeneous binding of UIC-2 and YB5.B8 to the blast population. For immunofluorescence labelling, all leukaemic and their different rates of Rh123 efflux (ranging from 0 to 95% of that of HEL-DR cells). Since it was previously shown specimens were assayed in duplicate and data were expressed as a percentage of the value obtained for HEL-DR cells. In that these specimens do not produce autocrine SCF, 14 we conclude that efflux activity is unlikely to be modulated by signalorder to determine whether any relationship existed between the parameters measured on 50 AML specimens, non-paraling through c-Kit. Recently the elucidation of non-Pgp-mediated efflux mechanisms has led to the identification of MRP, 24,25 p110 26 and correlated, the ability of SCF to modulate the MDR phenotype was examined. Pretreatment with the c-Kit ligand, SCF, for 10 p95. 27 In order to determine whether the relatively low corre-Pgp in the observed Rh123 efflux was tested by inclusion of 20 g/ml UIC-2 in the assay ( Figure 6 ). Efflux activity in sample 24 was completely inhibited and thus appeared to be mediated solely by Pgp, while HEL-DR showed approximately 20% of its efflux capacity to be non-Pgp mediated. Both KG1 and specimen 33 appear to have non-Pgp mechanisms contributing to the majority of their efflux.
Discussion
Pgp expression and drug efflux in AML specimens
Pgp expression is commonly detected in de novo AML and has been reported as having prognostic significance (eg Refs 2-5 and 29), although a recent review indicates its predictive value may be relatively low. 30 As pointed out by Hedley and co-workers, 19 this may be due to the inconsistent and often non-quantitative methodology for detection of Pgp in different studies and/or the existence of non-Pgp-mediated drug efflux mechanisms. In the current study of leukaemic blasts from 50 patients with de novo AML we have measured Pgp using two independent Mabs to extracellular epitopes of the protein (MRK-16 and UIC-2) by quantitative immunofluorescence and flow cytometry, and have also quantitated functional drug efflux using the fluorescent dye Rh123 as indicator. Since measurement of drug efflux at a single time point, as is commonly done in such assays, does not necessarily give a true indication of the rate of efflux, we have monitored Rh123 retention at several time points over a 40-min period. The difference in Rh123 retention between 10 and 40 min after resuspension of cells in Rh123-free medium was shown to correspond to the linear part of the efflux curve and to give a reliable indication of the rate of efflux. In agreement with the results of others, 19, 31 we demonstrated CsA-inhibitable drug efflux that could not be completely accounted for by Pgp as detected by the Mab. In the present study, the correlation between Pgp expression and Rh123 efflux (Figure 5b ; r s = 0.47, P = 0.0006) was higher than that observed previously by Xie et al 19 using MRK-16 and daunorubicin accumulation, yet lower than that found by Broxterman et were compared to the HEL-DR cell line. The involvement of al. 21 Perhaps the two most likely factors leading to such diswas a strong prognostic indicator, and was particularly predictive of whether or not the patient obtained a complete crepancies are the fluorescent probe, daunorubicin vs Rh123, and the MDR modulator, CsA vs PSC833, used for the quantitremission in response to standard chemotherapy with daunorubicin-cytosine arabinoside-6-thioguanine (DAT). 13 That ation of MDR function. These systems may differ in the extent to which they detect non-Pgp-mediated efflux mechanisms. study used relatively insensitive fluorescence methodology, and consequently underestimated the frequency of c-Kit Rh123 efflux could not be blocked by the functionally inhibitory UIC-2 Mab 28 in certain leukaemic specimens or in expression in AML (30% compared with more recent estimates of 66 and 87% of specimens). 14, 15 Thus the prognostic the KG1 myeloblastic leukaemic cell line ( Figure 6 ). This finding is in agreement with other reports that non-Pgp-mediated association should be considered as being with Kit BRIGHT , rather than positive or negative, as AML specimens display a efflux mechanisms exist in AML cells. 19, 27 Such mechanisms may explain the correlation of c-Kit level with Rh123 efflux continuum of c-Kit levels from negative to only slightly greater than the levels seen in normal CD34 + populations. 14 Although activity, but not Pgp expression in the leukaemic specimens screened ( Figure 5) Pgp 'over-expression' in de novo AML found between Rh123 efflux activity and c-Kit level (r s = 0.57; P = 0.0001). The inability of SCF pretreatment to modulate Although Pgp and functional drug resistance are commonly expressed in AML, it cannot be assumed that they are 'overexRh123 efflux demonstrates the intrinsic nature of the MDR phenotype and probably reflects the differentiation state of the pressed' since a proportion of normal bone marrow cells, including the majority of primitive haemopoietic progenitors leukaemic cell. In contrast to the primary AML specimens, no correlation between the level of c-kit and Rh123 efflux was ('long-term culture-initiating cells') have a Rh123 DULL , Pgp + phenotype. 1, 35, 36 The extent of Pgp expression and of funcobserved for the cell lines examined in this study (r s = −0.29, P = 0.39) which may reflect the relatively smaller number of tional drug efflux in de novo AML observed in this study was much lower than that of drug selected cell lines such as lines tested and the predominance of lines of more differentiated phenotypes (ie T cell, erythroblastic, megakaryoblastic CEM/VLB 100 . Furthermore, Pgp expression was in general comparable with that seen in CD34 + normal bone marrow and mast cell). The prognostic value of particular surface markers is frecell populations, approximately 3% that of the level seen in HEL-DR. Of the leukaemic specimens examined, 64% (32/50) quently controversial, which may in part be due to non-standard and often arbitrary methods of assigning positivity. For showed Pgp levels lower or comparable to normal CD34 + BMMNC.
example, CD34 positivity has been reported to be an indicator of poor prognosis in some studies (eg Refs 27 and 40), but not Only five specimens (three FAB M1, one M5, one M3) expressed Pgp at greater than double the level of CD34 + norin others (eg Refs 4 and 41). An association of Pgp expression and/or functional drug efflux with CD34 expression in AML mal BMMNC (ie 6% of HEL-DR); one of these had a level equivalent to 75% of that on HEL-DR cells, while the others has been observed in several studies. 4, 29, 31, 41, 42 Furthermore, consistent with the Rh123 DULL phenotype of primitve normal were between 6 and 10%. Therefore, in the majority of cases, Pgp expression did not appear to be appreciably upregulated haemopoietic progenitor cells, expression of Pgp and/or functional drug efflux has been associated with immature phenoat disease presentation. Thus, the level of Pgp expression in AML appears in general to reflect the phenotype of normal type in AML and myelodysplasia. [42] [43] [44] A likely scenario, then, is that poorly differentiated AML cells that express high levels cells at the corresponding stage of differentiation. While drugselected cell lines such as CEM/VLB 100 over-express Pgp by of c-Kit, 14 and possibly CD34, are inherently drug resistant due to their intrinsic capacity for functional drug efflux due virtue of gene amplification 18 none of the AML specimens in this study showed evidence of amplification by Southern to Pgp and/or other pumps. hybridization analysis (SR Cole and LK Ashman, unpublished data), which is in agreement with Holmes et al. 37 
